US stocks looked set to open little changed Thursday as investors digested major earnings reports as well as the latest initial jobless claims report.

Dow Jones Industrial Average futures were down 0.2%, S&P 500 futures were off 0.1%, and Nasdaq futures were marginally lower.

Initial jobless claims rose to 212,000 for the week ended Feb. 21 from 208,000 the previous week, compared with expectations for a larger increase to 216,000, according analysts polled by Bloomberg.

Nvidia (NVDA) reported late Wednesday fiscal Q4 results above analyst forecasts as an artificial intelligence boom continued to fuel computing demand.

Salesforce (CRM) shares were tracking lower pre-bell as the customer relationship management platform issued a weak full-year revenue outlook at the midpoint, even though fiscal Q4 results topped market estimates.

Oil prices were moving sharply lower, with front-month global benchmarks Brent crude falling 1.3% to $69.80, while West Texas Intermediate crude was down 1.8% to $64.25 a barrel.

In other world markets, Japan's Nikkei gained 0.3%, Hong Kong's Hang Seng shed 1.4%, and China's Shanghai Composite was little changed. Meanwhile in Europe's early afternoon session, the UK's FTSE 100 was up 0.2%, while Germany's DAX rose 0.5% and France's CAC rose 0.8%.

In equities, Healthcare Triangle (HCTI) shares were up 43% in premarket activity, after the company said overnight its QuantumNexis subsidiary collaborated with TNG Digital to provide clinically validated digital mental health services in Malaysia.

Nutanix (NTNX) was up nearly 12%, a day after the company reported higher fiscal Q2 adjusted earnings and revenue that also beat analysts' forecasts.

IonQ (IONQ) shares were up 15%, a day after it posted higher Q4 revenue, in addition to issuing higher-than-expected Q1 and 2026 outlook.

Shares of Celsius (CELH) gained 12% after report Q4 results that beat forecasts, according to analysts surveyed by FactSet.

On the losing side, Eos Energy Enterprises (EOSE) plunged nearly 30% pre-bell after it reported Q4 results and guidance that missed analyst forecasts by a wide margin.

The Trade Desk's (TTD) shares tumbled 15% after it provided Q1 guidance that fell short of Street expectations.

Chemed (CHE) shares were down 10% after it reported declining Q4 earnings that missed analyst forecasts, as did its 2026 adjusted EPS guidance.